MX362340B - Preparacion de intermediarios de agentes de contraste de rayos x. - Google Patents

Preparacion de intermediarios de agentes de contraste de rayos x.

Info

Publication number
MX362340B
MX362340B MX2015005981A MX2015005981A MX362340B MX 362340 B MX362340 B MX 362340B MX 2015005981 A MX2015005981 A MX 2015005981A MX 2015005981 A MX2015005981 A MX 2015005981A MX 362340 B MX362340 B MX 362340B
Authority
MX
Mexico
Prior art keywords
preparation
compound
intermediates
contrast agents
ray contrast
Prior art date
Application number
MX2015005981A
Other languages
English (en)
Other versions
MX2015005981A (es
Inventor
Haaland Torfinn
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of MX2015005981A publication Critical patent/MX2015005981A/es
Publication of MX362340B publication Critical patent/MX362340B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/14Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de agentes de contraste de rayos X yodados y en particular a intermediarios clave de los mismos. En particular se refiere a un proceso mejorado para la preparación de 5-acetamido-N, N'-bis(2,3-dihidroxipropil)-2,4,6-triyodoisoftalamida (Compuesto A) o N,N'-bis(2,3- dihidroxipropil)-5-formamido-2,4,6-triyodoisoft alamida (Compuesto C), los cuales son intermediarios en la preparación industrial de agentes de contrate de rayos X no iónicos. De manera más particular, la invención proporciona un proceso para la deacilación de los grupos hidroxilo acilados de un compuesto intermediario de Compuesto A y Compuesto C.
MX2015005981A 2012-11-12 2013-10-24 Preparacion de intermediarios de agentes de contraste de rayos x. MX362340B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12192193 2012-11-12
PCT/US2013/066487 WO2014074315A1 (en) 2012-11-12 2013-10-24 Preparation of intermediates of x-ray contrast agents

Publications (2)

Publication Number Publication Date
MX2015005981A MX2015005981A (es) 2015-09-10
MX362340B true MX362340B (es) 2019-01-11

Family

ID=47146268

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015005981A MX362340B (es) 2012-11-12 2013-10-24 Preparacion de intermediarios de agentes de contraste de rayos x.

Country Status (15)

Country Link
US (1) US9403757B2 (es)
EP (1) EP2917174B1 (es)
JP (1) JP6248119B2 (es)
KR (1) KR102172700B1 (es)
CN (2) CN104768921A (es)
AU (1) AU2013341615B2 (es)
BR (1) BR112015006502B1 (es)
CA (1) CA2881707C (es)
ES (1) ES2692071T3 (es)
IN (1) IN2015DN01143A (es)
MX (1) MX362340B (es)
PL (1) PL2917174T3 (es)
PT (1) PT2917174T (es)
RU (1) RU2659214C2 (es)
WO (1) WO2014074315A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT108524B (pt) * 2015-06-02 2017-12-15 Hovione Farmaciência S A Processo para a preparação de intermediários úteis na preparação de agentes de contraste não-iónicos
CN108752230B (zh) * 2018-07-12 2020-11-03 浙江海洲制药有限公司 一种造影剂碘克沙醇杂质e的关键中间体的合成方法
KR102128423B1 (ko) 2018-09-17 2020-07-01 (주)유케이케미팜 조영제 이오메프롤의 제조방법
EP4001261A1 (en) * 2020-11-23 2022-05-25 Justesa Imagen S.A.U Procedure for obtaining high purity iohexol
CN114853625A (zh) * 2022-03-31 2022-08-05 海南普利制药股份有限公司 一种工业化生产碘海醇中间体的方法
CN114989034B (zh) * 2022-06-28 2024-02-23 浙江海洲制药股份有限公司 一种碘海醇杂质的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0108638B1 (en) 1982-11-08 1986-07-16 NYEGAARD & CO. A/S X-ray contrast agents
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
GB9624612D0 (en) 1996-11-26 1997-01-15 Nycomed Imaging As Process
GB9903109D0 (en) * 1999-02-11 1999-04-07 Nycomed Imaging As Process
IT1319670B1 (it) * 2000-12-01 2003-10-23 Bracco Spa Processo per la preparazione di 5-ammino-n,n'-bis(2-idrossi-1-(idrossimetil)etil))-1,3-benzendicarbossammide (i) e 5-ammino-n,n'-
ITMI20010773A1 (it) * 2001-04-11 2002-10-11 Chemi Spa Processo per la produzione di ioexolo ad elevata purezza
NO20043305D0 (no) * 2004-08-09 2004-08-09 Amersham Health As Preparation of lodixanol
ES2486296T3 (es) * 2007-07-12 2014-08-18 Ge Healthcare As Agentes de contraste
US20110021822A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As continuous deacetylation and purification process in synthesis of non-ionic x-ray contrast agents
US20110021828A1 (en) * 2009-07-21 2011-01-27 Ge Healthcare As Recovering unreacted intermediate from desalinated and desolventized dimerisation reaction mixture by ultrafiltration

Also Published As

Publication number Publication date
RU2015114789A (ru) 2017-01-10
BR112015006502A2 (pt) 2017-07-04
CA2881707C (en) 2021-01-12
IN2015DN01143A (es) 2015-06-26
EP2917174A4 (en) 2016-06-08
WO2014074315A1 (en) 2014-05-15
EP2917174A1 (en) 2015-09-16
EP2917174B1 (en) 2018-09-12
KR102172700B1 (ko) 2020-11-03
ES2692071T3 (es) 2018-11-30
AU2013341615B2 (en) 2017-12-14
JP6248119B2 (ja) 2017-12-13
KR20150082293A (ko) 2015-07-15
CN110229079A (zh) 2019-09-13
AU2013341615A1 (en) 2015-02-26
MX2015005981A (es) 2015-09-10
US20150274645A1 (en) 2015-10-01
CN104768921A (zh) 2015-07-08
BR112015006502B1 (pt) 2021-03-09
PT2917174T (pt) 2018-11-14
CA2881707A1 (en) 2014-05-15
JP2016501184A (ja) 2016-01-18
US9403757B2 (en) 2016-08-02
RU2659214C2 (ru) 2018-07-05
PL2917174T3 (pl) 2019-01-31

Similar Documents

Publication Publication Date Title
MX2015005981A (es) Preparacion de intermediarios de agentes de contraste de rayos x.
MX2013006378A (es) Catalizadores de blanqueo.
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
PH12014502697B1 (en) New diazaspirocycloalkane and azaspirocycloalkane
MX2013002264A (es) Composiciones pesticidas.
MX2013004338A (es) Secuencias de repeticiones palindromicas cortas separadas regularmente agrupadas-cas (crisp-cas).
BRPI1005940A2 (pt) processo para preparar compostos de 2-nitrobifenila de fórmula i, compostos de 2-aminobifenila de fórmula vi, n-acil-2-aminobifenilas da fórmula geral (vii), composto de fórmula i, composto de fórmula ii, composto de fórmula iii e composto de fórmula x.1 ou x.2
MX2014015197A (es) Tratamiento y prevencion de la enfermedad cardiovascular y trombosis.
BR112015009034A2 (pt) método para a preparação de uma suspensão aquosa, suspensão aquosa, e, uso de uma suspensão aquosa
MX2013000793A (es) Composicion que contiene galacto-oligosacarido y un metodo para producirla.
BR112012004652A2 (pt) composições de soluções concentradas compreendendo metal do grupo vi, metal do grupo viii e fósforo e processo de formação
BR112013003121A2 (pt) moduladores de trpv3
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
BR112012022090A2 (pt) utilização de ácido elágico como agente anticaspa
MX2012007142A (es) Uso de 2,3-dihidroxipropil dodecanoato para tratar seborrea.
MX2012002299A (es) Uso de cetoenoles ciclicos contra bacterias fitopatogenas.
PH12014500158B1 (en) Preparation of (r)- and (s)-n-(3, 4-difluoro-2-(2-fluoro-4-iodophenylamino)--6-methoxyphenyl) -1- (2, 3-dihydroxypropyl)cyclopropane-1-sulfonamide and protected derivatives thereof
MX2013003859A (es) Polimorfos de picropodofilina b o c para su uso en la terapia del cancer.
NZ708503A (en) Purification of x-ray contrast agents
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
IN2015DN03944A (es)
IT1403988B1 (it) Processo per la preparazione di agenti di contrasto.
IN2015DN01186A (es)
IN2015DN01185A (es)
BR112013013306A8 (pt) Processos para a preparação de enaminas

Legal Events

Date Code Title Description
FG Grant or registration